How effective and safe is the Sinopharm vaccine to be applied in the country?



Javier Maldonado

Monday 26, July 2021 • 4:48 pm

The Chinese BBIBP-CorV Sinopharm vaccine, developed from the inactivated virus, received on May 7, 2021, the endorsement of the Strategic Advisory Group on Immunization (SAGE) of the World Health Organization (WHO) for use in emergency.

According to the WHO the vaccine Sinopharm should be applied to people over 18 years of age in two doses three to four weeks apart.

Although studies on pregnant women are “insufficient” the WHO assures on its website that “It is an inactivated vaccine with an adjuvant that is commonly used in many other vaccines with a good documented safety profile, even in pregnant women.”

SAGE has carefully evaluated the data on the quality, safety and efficacy of the vaccine and has recommended its use for people over 18 years of age ”. WHO

Experts also recommend that the vaccine be offered to people who have suffered from covid-19 “Within 6 months of an initial natural infection.”

In the WHO recommendations, it says that clinical studies on the Sinopharm vaccine estimate that “The efficacy of the vaccine to avoid symptoms and hospitalizations exceeds 79% (for all age groups).”

The Sinopharm vaccine whose multicountry phase 3 trial showed that with two doses, administered at an interval of 21 days, have a high efficacy of more than 79%, 95% to avoid hospitalizations, and between 66% and 87% against symptomatic SARS-CoV-2 infection 14 or more days after the second dose.

Countries that are considering using this vaccine in people over 60 years of age should maintain active safety monitoring ”. WHO

“People living with HIV were not included in the trial, but since it is a vaccine that does not replicate,” the WHO estimates that the vaccine is recommended.

Who is the vaccine not recommended for?

According to the experts, they should not be applied to people with a history of anaphylaxis to any component of the vaccine, nor to those who have a body temperature above 38.5ºC at the vaccination post. For these patients, the vaccination should be postponed until the fever is gone.

© Copyright EL MUNDO | News from El Salvador and the world. All rights reserved 2021



Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.